The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer
- PMID: 25800313
The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer
Abstract
Background: The arm lymphedema is reported as being the most frequent late reaction and complication that influences breast cancer patients' quality of life after lymph node dissection and radiotherapy. The aim of the study is to identify the risk factors in arm lymphedema occurrence in breast cancer patients who performed radical conservatory surgery, chemotherapy and radiotherapy.
Material and methods: We analysed 305 breast cancer patients who underwent treatment in the "Sf. Ap. Andrei" Emergency Clinical Hospital, Galati, Radiotherapy and Oncology Department, between the 1st of January 2010 and 31st of December 2012. We tried to find the risk factors for arm lymphedema development after treatment of breast cancer: the association of adjuvant radiotherapy with surgery, chemotherapy,hormonal therapy, number of removed lymph nodes,and number of lymph nodes with metastases, the co-morbid illnesses (obesity, diabetes mellitus and high blood pressure).
Results: Our study evidences that the association of adjuvant radiotherapy, including the lymph node regions, with radical or conservatory surgery with lymph node dissection represents a statistically significant risk factor, with relative risk, RR =1.87, 95%C.I.=1.39-3.51, p<0.001. The number of removed lymph nodes was found to be a risk factor with statistical significance. For more than 25 removed lymph nodes, the relative risk for arm lymphedema development was RR=1.95(95%C.I. =1.79-4.51) and for 16-25 removed lymph nodes the relative risk, RR = 1.78, 95% C.I. = 1.46 - 3.23. Other analysed risk factors, which did not influence lymphedema development, were: associated chemotherapy or hormonal therapy,presence of co-morbid illnesses.
Conclusions: The development of arm lymphedema is an unpredictable occurrence that can happen years after axillary surgery.Breast and arm oedema continue to be late reactions that can be reduced by use of biopsy sentinel technique with avoiding of axillary lymph node dissection, when the sentinel lymph node is negative, knowing that lymphedema risk after sentinel lymph node is 5% comparative with lymphedema risk after axillary lymph node dissection which is 16%, by avoiding obesity, and performing modern therapy techniques.
Celsius.
Similar articles
-
Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x. Epub 2009 Nov 2. Breast J. 2010. PMID: 19889169
-
The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.Eur J Surg Oncol. 2014 Jul;40(7):818-23. doi: 10.1016/j.ejso.2014.03.023. Epub 2014 Apr 15. Eur J Surg Oncol. 2014. PMID: 24768416
-
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765. Orv Hetil. 2013. PMID: 24292111 Clinical Trial. Hungarian.
-
[Management of the axilla in breast cancer: evidences and unresolved issues].Orv Hetil. 2001 Sep 9;142(36):1941-50. Orv Hetil. 2001. PMID: 11680099 Review. Hungarian.
-
Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction.Cancer J. 2008 Jul-Aug;14(4):216-22. doi: 10.1097/PPO.0b013e31817fbe5e. Cancer J. 2008. PMID: 18677128 Review.
Cited by
-
Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.Ann Surg Oncol. 2021 Dec;28(13):8624-8633. doi: 10.1245/s10434-021-10173-0. Epub 2021 Jun 11. Ann Surg Oncol. 2021. PMID: 34117574
-
Associated risk factors of lower limb lymphedema after treatment of cervical and endometrial cancer.Exp Ther Med. 2020 Dec;20(6):181. doi: 10.3892/etm.2020.9311. Epub 2020 Oct 13. Exp Ther Med. 2020. PMID: 33101471 Free PMC article.
-
Development of a core outcome set for breast cancer-related lymphedema: a Delphi study.Breast Cancer Res Treat. 2024 Jun;205(2):359-370. doi: 10.1007/s10549-024-07262-5. Epub 2024 Feb 29. Breast Cancer Res Treat. 2024. PMID: 38424364 Free PMC article.
-
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer-Related Lymphedema: a Systematic Review.Curr Oncol Rep. 2023 Sep;25(9):1031-1046. doi: 10.1007/s11912-023-01439-9. Epub 2023 Jul 4. Curr Oncol Rep. 2023. PMID: 37402044 Free PMC article.
-
Level III dissection in locally advanced breast cancer following neoadjuvant chemotherapy: a retrospective study.Ann R Coll Surg Engl. 2020 Mar;102(3):214-219. doi: 10.1308/rcsann.2019.0142. Epub 2019 Nov 22. Ann R Coll Surg Engl. 2020. PMID: 31755729 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical